EarningsSQURPHARMA
SQURPHARMA Earnings Update — FY 2022–23
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 23 October 2023. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of SQURPHARMA): The Company has also reported Consolidated EPS of Tk. 21.41, Consolidated NAV per share of Tk. 129.95 and Consolidated NOCFPS of Tk. 9.64 for the year ended June 30, 2023 as against Tk. 20.48, Tk. 118.68 and Tk. 14.52 respectively for the year ended June 30, 2022. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(SQURPHARMA-এর ধারাবাহিক খবর): কোম্পানিটিও টাকা একত্রিত EPS রিপোর্ট করেছে। 21.41, শেয়ার প্রতি একত্রিত NAV টাকা 129.95 এবং একত্রিত NOCFPS টাকা। 30 জুন, 2023 সমাপ্ত বছরের জন্য 9.64 টাকার বিপরীতে। 20.48, টাকা 118.68 এবং টাকা 30 জুন, 2022 সমাপ্ত বছরের জন্য যথাক্রমে 14.52। (শেষ)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6535ec799b63f84212ce8950
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.